Products

COVID-19 Coronavirus Receptor Stable Cell Lines

[tab:General information] GeneCopoeia has produced HEK293T cell lines expressing ACE2 and TMPRSS2, two human host factors needed for efficient infection by SARS-CoV-2, the virus responsible for the COVID-19 pandemic. These cell lines express ACE2 and/or TMPRSS2 mRNA...
read more

COVID-19 Coronavirus Lentiviral and AAV Solutions

[tab:General information] GeneCopoeia carries complete suites of state-of-the-art products for gene delivery using lentivirus and adenoassociated virus (AAV). GeneCopoeia's lentiviral solutions include: Lentiviral plasmids. Available for expressing ORF cDNAs, gene...
read more

COVID-19 Coronavirus Plasmid Clones

[tab:General information] GeneCopoeia is the industry leader in expression-ready ORF cDNA clones, and we also carry reporter plasmid clones carrying gene promoters and 3' UTR microRNA (miRNA) binding site targets. OmicsLink™ SARS-CoV-2-related ORF cDNA plasmid...
read more

Lentifect™ SARS-CoV-2 Spike-Pseudotyped Lentivirus

GeneCopoeia's Lentifect™ SARS-CoV-2 Spike-pseudotyped lentivirus products produce a specially-packaged version of standard lentivirus, whereby the vesicular stomatitis G (VSV-G) envelope glycoprotein is replaced by the Spike (S) protein from SARS-CoV-2, the...
read more

Reagents

GeneCopoeia, Inc. a U.S.-based functional genomics company founded in 1999, develops cutting edge products and services for genomics, proteomics, and molecular and cellular biology. With emphasis on...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.